Relay Therapeutics Inc (RLAY) — Cash Flow Reinvestment Rate
Latest as of March 2021:
5.01x
Relay Therapeutics Inc (RLAY) has a Cash Flow Reinvestment Rate of 5.01x as of March 2021, reinvesting $233.62 Million (capex $476.00K plus investments $-233.15 Million) from operating cash flow of $46.64 Million. Check cash flow quality index of Relay Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
5.01x
(Capex + Investments) / Operating CF
Total Reinvested
$233.62 Million
Capex + Investments
Operating Cash Flow
$46.64 Million
USD
Capital Expenditures
$476.00K
USD
Annual Cash Flow Reinvestment Rate for Relay Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Relay Therapeutics Inc. For live market cap and broader valuation context, see RLAY market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow